Amongthe synthetic ligands, fibrates are hypolipidemic compounds that activate PPARα, and TZDs, which selectively activatePPARγ, are hypoglycaemic molecules that areused to treat type 2 diabetes. Here, PPARA is linked to type 2 diabetes mellitus.